Pharmaceutical Manufacturing Handbook: Production and

862 VAGINAL DRUG DELIVERY
suppositories and an approved progesterone vaginal gel , Drug. Dev. Ind. Pharm. , 30 ,
1069 – 1078 .
88. Zaneveld , L. J. , Waller , D. P. , Ahmad , N. , Quigg , J. , Kaminski , J. , Nikurs , A. , and De Jonge ,
C. ( 2001 ), Properties of a new, long - lasting vaginal delivery system (LASRS) for contraceptive
and antimicrobial agents , J. Androl. , 22 , 481 – 490 .
89. Ladipo , O. A. , De Castro , M. P. , Filho , L. C. , Coutinho , E. , Waller , D. P. , Cone , F. , and
Zaneveld , L. J. ( 2000 ), A new vaginal antimicrobial contraceptive formulation: Phase I
clinical pilot studies , Contraception , 62 , 91 – 97 .
90. Mandal , T. K. ( 2000 ), Swelling - controlled release system for the vaginal delivery of
miconazole , Eur. J Pharm. Biopharm. , 50 , 337 – 343 .
91. Merabet , J. , Thompson , D. , and Saul Levinson , R. ( 2005 ), Advancing vaginal drug delivery
, Expert Opin. Drug. Deliv. , 2 , 769 – 777 .
92. Seidman , L. S. , and Skokos , C. K. ( 2005 ), An evaluation of butoconazole nitrate 2% site
release vaginal cream (Gynazole - 1) compared to fl uconazole 150 mg tablets (Difl ucan)
in the time to relief of symptoms in patients with vulvovaginal candidiasis , Infect. Dis.
Obstet. Gynecol. , 13 , 197 – 206 .
93. Levinson , R. S. , Mitan , S. J. , Steinmetz , J. I. , Gattermeir , D. J. , Schumacher , R. J. , and
Joffrion , J. L. ( 2005 ), An open - label, two - period, crossover study of the systemic bioavailability
in healthy women of clindamycin phosphate from two vaginal cream formulations
, Clin. Ther. , 27 , 1894 – 1900 .
94. del Palacio , A. , Sanz , F. , Sanchez - Alor , G. , Garau , M. , Calvo , M. T. , Boncompte , E. ,
Alguero , M. , Pontes , C. , and Gomez de la Camara , A. ( 2000 ), Double - blind randomized
dose - fi nding study in acute vulvovaginal candidosis. Comparison of fl utrimazole site -
release cream (1, 2 and 4%) with placebo site - release vaginal cream , Mycoses , 43 ,
355 – 365 .
95. Wichterle , O. , and Lim , D. ( 1960 ), Hydrophilic gels in biologic use , Nature , 185 , 117 .
96. Justin - Temu , M. , Damian , F. , Kinget , R. , and Van Den Mooter , G. ( 2004 ), Intravaginal
gels as drug delivery systems , J. Womens Health (Larchmt.) , 13 , 834 – 844 .
97. das Neves , J. , and Bahia , M. F. ( 2006 ), Gels as vaginal drug delivery systems , Int. J. Pharm. ,
318 , 1 – 14 .
98. Milani , M. , Molteni , B. , and Silvani , I. ( 2000 ), Effect on vaginal pH of a polycarbophil
vaginal gel compared with an acidic douche in women with suspected bacterial vaginosis:
A randomized, controlled study , Curr. Ther. Res. Clin. Exp. , 61 , 781 – 788 .
99. Robinson , J. R. , and Bologna , W. J. ( 1994 ), Vaginal and reproductive system treatments
using a bioadhesive polymer , J. Controlled Release , 28 , 87 – 94 .
100. D ’ Cruz , O. J. , and Uckun , F. M. ( 2001 ), Gel - microemulsions as vaginal spermicides and
intravaginal drug delivery vehicles , Contraception , 64 , 113 – 123 .
101. Knuth , K. , Amiji , M. , and Robinson , J. R. ( 1993 ), Hydrogel delivery systems for vaginal
and oral applications: Formulation and biological considerations , Adv. Drug Deliv. Rev. ,
11 , 137 – 167 .
102. Venkatraman , S. , Davar , N. , Chester , A. , and Kleiner , L. ( 2005 ), An overview of controlled
release systems , in Wise , D. L. , Ed., Handbook of Pharmaceutical Controlled
Release Technology , Marcel Dekker , New York , pp 431 – 464 .
103. Okada , H. , Yamazaki , I. , Ogawa , Y. , Hirai , S. , Yashiki , T. , and Mima , H. ( 1982 ), Vaginal
absorption of a potent luteinizing hormone - releasing hormone analog (leuprolide) in
rats I: Absorption by various routes and absorption enhancement , J. Pharm. Sci. , 71 ,
1367 – 1371 .
104. Rosenberg , M. J. , Phillips , R. S. , and Holmes , M. D. ( 1991 ), Vaginal douching. Who and
why ? J. Reprod. Med. , 36 , 753 – 758 .